Personalized risk stratification integrating age, arrhythmias, right ventricular remodeling, and comorbidities should guide adult atrial septal defect management rather than universal closure.
Adult ASD management should transition from universal closure to personalized, risk-stratified treatment pathways within specialized adult congenital heart disease programs.
Absolute Event Rate: 0% vs 0%
Risk-based decision-making should be central to adult ASD management, integrating age, atrial arrhythmia burden, right ventricular (RV) remodeling, pulmonary vascular disease, and comorbidities This review translates existing evidence into a practical decision-oriented framework. Future strategies should move away from a 'one-size-fits-all' closure approach toward personalized treatment pathways within specialized adult congenital heart disease (ACHD) programs.
Si̇nan et al. (Mon,) reported a other. Personalized risk stratification integrating age, arrhythmias, right ventricular remodeling, and comorbidities should guide adult atrial septal defect management rather than universal closure.